TNFA

TNF Pharmaceuticals, Inc. Common Stock
TNFA

Overview Fund Activity

41 hedge funds and large institutions have $2.52M invested in TNF Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
10
Closed
5
Calls
$35K
Puts
$120K
Net Calls
-$85K
Net Calls Change
+$47K

Top Buyers

1
PWM
1
Praetorian Wealth Management
California
$118K
2
CIM
2
Cambria Investment Management
California
$102K
3
Millennium Management
3
Millennium Management
New York
$64.3K
4
AB
4
Atlas Brown
Kentucky
$25.8K
5
XT
5
XTX Topco
Cayman Islands
$23.4K

Top Sellers

1
Mirae Asset Global Investments
1
Mirae Asset Global Investments
South Korea
$557K
2
MHS
2
M Holdings Securities
Oregon
$0
3
Wells Fargo
3
Wells Fargo
California
$3.09K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$7.31K
Name Holding Trade Value Shares
Change 		Shares
Change %
MHS
51
M Holdings Securities
Oregon
– -$106K -24 Closed
Citadel Advisors
52
Citadel Advisors
Florida
– -$42K -9 Closed
HF
53
HRT Financial
New York
– -$22K -5 Closed
Charles Schwab
54
Charles Schwab
California
– -$20.9K -5 Closed
FTUS
55
Flow Traders U.S.
New York
– -$18K -4 Closed
GWM
56
Geneos Wealth Management
Colorado
– -$1.09K – –
AWM
57
Avior Wealth Management
Nebraska
– -$216 – –
TWC
58
TD Waterhouse Canada
Ontario, Canada
– -$53 – –
1 2
3